NuVasive to Sponsor and Participate at the Cervical Spine Research Society 50th Annual Meeting

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA) is reaffirming its role as a diamond sponsor for the Cervical Spine Research Society (CSRS) 50th Annual Meeting from November 16 to 19 in San Diego. The event highlights NuVasive's commitment to advancing cervical technology, particularly with the recent launch of its Reline Cervical solution. CEO Chris Barry emphasizes the importance of their C360 portfolio and its integration with Pulse technology at this influential meeting. Two workshops will showcase pioneering techniques in spinal surgery.

Positive

• Continued partnership with CSRS strengthens brand presence.
• Launch of Reline Cervical enhances product offerings.
• Showcasing C360 portfolio may attract new clients and partnerships.

Negative

• None.

SAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50^th Annual Meeting held November 16 to 19 in San Diego.

"The recent launch of our leading posterior cervical fusion solution, Reline Cervical, and our annual meeting sponsorship of a preeminent cervical society, CSRS, underscores our shared belief in further advancing cervical technology," said Chris Barry, chief executive officer at NuVasive. "We look forward to showcasing our comprehensive, procedurally integrated C360 portfolio, and its initial step toward intelligent surgery with full Pulse compatibility."

NuVasive will host two workshops on Thursday, November 17 in room Hillcrest CD. From 6:30 to 7:15 a.m. PT, a hands-on workshop, TDR: What are you waiting for? Fantasy vs. reality, featuring Dr. Ali Mesiwala, DISC Sports and Spine Center, and Dr. Rory Murphy, Barrow Neurological Institute. From 11:30 a.m. to 12:30 p.m. PT, an industry lunch workshop, Approaching cervicothoracic kyphotic deformities—anterior, posterior and 360, featuring Dr. Praveen Mummaneni, UCSF Health, Dr. Rick Sasso, Indiana Spine Hospital, and Dr. Todd Albert, Hospital for Special Surgery.

NuVasive booth #105/204 will feature the Company's full C360™ portfolio, made up of best-in-class access instrumentation, implants, biologic materials, and enabling technologies within Pulse^® for the anterior and posterior cervical spine.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-the-cervical-spine-research-society-50th-annual-meeting-301676684.html

SOURCE NuVasive, Inc.

FAQ

What is NuVasive's role at the CSRS 50th Annual Meeting?

NuVasive is a diamond sponsor and will present its C360 portfolio, highlighting its Reline Cervical solution.

When is the CSRS 50th Annual Meeting scheduled?

The CSRS 50th Annual Meeting is scheduled from November 16 to 19, 2022.

What workshops will NuVasive conduct during the meeting?

NuVasive will host two workshops on November 17, focusing on TDR techniques and cervicothoracic kyphotic deformities.

How does NuVasive aim to advance cervical technology?

NuVasive aims to advance cervical technology through its C360 portfolio and the recent launch of the Reline Cervical product.

What products will NuVasive showcase at the CSRS meeting?

NuVasive will showcase its comprehensive C360™ portfolio, which includes access instrumentation, implants, and biologic materials.